BioCentury
ARTICLE | Company News

RedHill, Scolr Pharma deal

May 17, 2010 7:00 AM UTC

SCOLR granted RedHill exclusive, worldwide rights to market ondansetron tablets formulated with SCOLR's CDT extended delivery technology. SCOLR will receive up to $600,000 in upfront and milestone pay...